My secondment in Cambridge

My project involves Next Generation Sequencing (NGS) analysis of melanoma samples to understand resistance mechanisms to immunotherapy. Dr. Adams, who is one of the principal investigators of our Marie-Curie Ph.D. program based at the Wellcome Trust Sanger Institute in Cambridge, offered his help and expertise to perform the bioinformaticRead More